Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Giải trình biến động LNST trên BCTC quý 1/2026 so với cùng kỳ năm trước
Regulatory Filings Classification · 86% confidence The document is a periodic regulatory disclosure filed on the State Securities Commission and Ho Chi Minh Stock Exchange portals explaining the Q1/2026 vs Q1/2025 profit variances. It does not constitute a full interim or annual report (lacks full financial statements) and is not an announcement of an attached report. This type of standalone explanation is a general regulatory filing under Vietnam’s stock exchange rules. Therefore it should be classified as a Regulatory Filing (RNS).
2026-04-20 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của Người nội bộ Dương Hoàng Vũ
Director's Dealing Classification · 91% confidence The document is a formal notice of transactions in shares, fund certificates, or covered warrants by an internal person (Chief Accountant) of Imexpharm Corporation. It details the insider’s personal share transaction information (number of shares held before and after, transaction type, purpose, expected timing). This matches the definition of Director’s Dealing (Code: DIRS) for reporting personal share transactions by company insiders.
2026-04-15 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của tổ chức có liên quan của Người nội bộ SK Investment Vina III Pte. Ltd., Công ty Cổ phần Đầu tư Bình Minh Kim, Công ty Cổ phần Đầu tư KBA
Director's Dealing Classification · 88% confidence The document is a formal disclosure to the State Securities Commission and stock exchanges detailing a major shareholder’s sale of IMP shares, where that shareholder is related to an insider (board member). It is not a financial report, dividend notice, or bond interest update, but rather a notification of insider-related share transactions. This aligns with the “Director’s Dealing” category (DIRS), which covers insider and related-party share dealings.
2026-04-15 Vietnamese
IMP: Giấy phép môi trường Nhà máy Công nghệ cao Bình Dương
Regulatory Filings Classification · 90% confidence The document is an irregular disclosure submitted to the State Securities Commission and stock exchange, announcing the grant of an environmental license by the Ho Chi Minh City Management Board of Export Processing Zones and Industrial Parks. It contains regulatory and compliance information rather than financial statements, voting results, or management discussions. This falls under general regulatory filings as it does not match any other specific category.
2026-04-10 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của Người nội bộ Huỳnh Văn Nhung
Director's Dealing Classification · 89% confidence The document is a formal notice of an insider transaction (“Giao dịch cổ phiếu … của người nội bộ và người có liên quan của người nội bộ”) by a company executive, detailing the number of shares held before and after, the purpose, method, and expected trading period. This corresponds to insider share dealings by company directors or executives, matching the Director's Dealing category.
2026-04-10 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của Người nội bộ Ngô Minh Tuấn, Trần Thị Đào
Director's Dealing Classification · 95% confidence The document is a regulatory notice detailing personal share transactions by a company insider (Trần Thị Đào), including holdings before and after, transaction purpose, method, and timeframe. This matches the definition of a Director’s Dealing (insider trading) report.
2026-04-09 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.